Nemaura Medical IncOTC Pink - Current Information:NMRD
- LAST PRICE0.0650
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0600/ 100
- Ask / Lots0.0750/ 100
- Open / Previous Close0.0000 / 0.0650
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRD |
|---|---|---|
| 09:38 ET | 150 | 0.075 |
| 09:39 ET | 200 | 0.0684 |
| 10:26 ET | 500 | 0.0618 |
| 10:28 ET | 7772 | 0.0618 |
| 11:24 ET | 26911 | 0.06 |
| 11:45 ET | 1594 | 0.06 |
| 12:03 ET | 4500 | 0.063 |
| 01:37 ET | 1000 | 0.0659 |
| 03:07 ET | 560 | 0.066 |
| 03:39 ET | 800 | 0.065 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nemaura Medical Inc | 1.9M | -0.2x | --- |
Hawkeye Systems Inc | 1.6M | -1.4x | --- |
Dror Ortho-Design Inc | 2.5M | -0.5x | --- |
Golden Valley Development Inc | 2.5M | 0.0x | --- |
Bone Biologics Corp | 1.3M | 0.0x | --- |
Therapeutic Solutions International Inc | 2.5M | -0.9x | --- |
Company Information
Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The Company is commercializing sugarBEAT and proBEAT. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and also be used to screen pre-diabetic patients. The sugarBEAT device extracts from analytes, such as glucose, from the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor. The proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service.
Contact Information
- Headquarters
- 57 W 57th StNEW YORK, NY, United States 10019-2802
- Phone
- 150-922-2912
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer
- Dewan Chowdhury
- Chief Operating Officer
- Arash Ghadar
- Director
- Asim Butt
- Director
- Ruhksana Qayyum
- Independent Director
- Timothy Johnson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 28.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.00 |
EPS | $-0.38 |
Book Value | $-0.41 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
